Protalix BioTherapeutics
PLX
#8648
Rank
€73 M
Marketcap
0,99 €
Share price
-4.35%
Change (1 day)
-38.10%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): 0,08286 €

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is 0,09024 €. In 2022 the company made an earnings per share (EPS) of -0,27 € an increase over its 2021 EPS that were of -0,56 €.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,08286 €-130.61%
2022-0,27 €-51.61%
2021-0,56 €342.86%
2020-0,13 €-88.71%
2019-1,12 €-34.74%
2018-1,71 €-70.92%
2017-5,90 €2153.35%
2016-0,26 €-146.77%
20150,56 €-287.88%
2014-0,30 €10%
2013-0,27 €130.77%
2012-0,12 €-56.67%
2011-0,27 €-46.43%
2010-0,51 €36.59%
2009-0,37 €32.26%
2008-0,28 €-93.4%
2007-4,24 €1298.53%
2006-0,30 €-96.59%
2005-8,90 €19.32%
2004-7,46 €1552.65%
2003-0,45 €-0%
2002-0,45 €-50%
2001-0,90 €233.33%
2000-0,27 €-83.09%
1999-1,60 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,58 €-740.00%🇺🇸 USA
1,77 € 1,860.00%🇺🇸 USA
1,68 € 1,760.00%🇺🇸 USA
-1,80 €-2,100.00%🇮🇱 Israel